NEW YORK, Sept. 5 – Structural Bioinformatics and ChemNavigator have agreed to combine their technologies in order to identify novel drug candidates, SBI announced on Wednesday.

According to the terms of the agreement, SBI and its customers will have access to ChemNavigator’s iResearch System, a database of chemical structures for 2 million drug-like compounds. This information can then be screened against SBI’s own drug-target database of three-dimensional protein structures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.